MedTrace Logo

Weight Management After Cancer for Survivors in Rural Communities

NCT07426952 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-19

No results posted yet for this study

Summary

This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment.

The study will answer two main questions:

* Can study team successfully recruit and keep participants in the study, and will the participants find the program helpful and easy to follow?
* Will participants who join the program see better results in areas like weight, symptoms, diet, physical activity, and confidence in managing the participant's health compared to those who receive standard care?

Here's what participants will do:

* Visit the participant's clinic twice (about 12 weeks apart) to be weighed, have the blood pressure checked, give a blood sample, and complete a short walking test
* Fill out online surveys about the participant's health, diet, physical activity, symptoms, and confidence in managing the participant's health
* Be randomly assigned (like flipping a coin) to either receive the WeCan-Rural program or standard health information
* If assigned to the program, attend 12 weekly one-hour video sessions on Zoom with a trained therapist

Conditions

Interventions

BEHAVIORAL

WeCan-Rural Program

The WeCan-Rural program includes 12, one-hour weekly sessions via Zoom that help breast cancer survivors manage symptoms like pain, fatigue, and emotional distress, while also building healthy habits around eating, exercise, and weight management.

Sponsors & Collaborators

Principal Investigators

  • Caroline Dorfman, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-13
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07426952 on ClinicalTrials.gov